Par Pharma Shareholders Seek Settlement Approval

Law360, New York (June 30, 2008, 12:00 AM EDT) -- Par Pharmaceuticals Co. Inc. agreed Friday to overhaul its accounting practices as part of a proposed settlement to a shareholder derivative suit over losses allegedly incurred from falsified business reports.

Par shareholders are seeking approval for the settlement in a motion filed in the U.S. District Court for New Jersey. The agreement includes a $200,000 payment to the shareholders' lawyers.

The agreement comes days after a New Jersey district judge tossed a related consolidated class action suit against Par and four of its top executives....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.